Carvedilol-RPM may be available in the countries listed below.
Ingredient matches for Carvedilol-RPM
Carvedilol is reported as an ingredient of Carvedilol-RPM in the following countries:
- Luxembourg
International Drug Name Search
Carvedilol-RPM may be available in the countries listed below.
Carvedilol is reported as an ingredient of Carvedilol-RPM in the following countries:
International Drug Name Search
Zinc Undecylenate may be available in the countries listed below.
Zinc Undecylenate (JAN) is known as Undecylenic Acid in the US.
International Drug Name Search
Glossary
JAN | Japanese Accepted Name |
Fenazopiridina Farmindustria may be available in the countries listed below.
Phenazopyridine is reported as an ingredient of Fenazopiridina Farmindustria in the following countries:
International Drug Name Search
In the US, Roxicodone (oxycodone systemic) is a member of the drug class narcotic analgesics and is used to treat Pain.
US matches:
Oxycodone hydrochloride (a derivative of Oxycodone) is reported as an ingredient of Roxicodone in the following countries:
International Drug Name Search
Algin-Vek may be available in the countries listed below.
Tenoxicam is reported as an ingredient of Algin-Vek in the following countries:
International Drug Name Search
Hercarenone may be available in the countries listed below.
Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Hercarenone in the following countries:
International Drug Name Search
Gabapentine CF may be available in the countries listed below.
Gabapentin is reported as an ingredient of Gabapentine CF in the following countries:
International Drug Name Search
Epinefrina Life may be available in the countries listed below.
Epinephrine hydrochloride (a derivative of Epinephrine) is reported as an ingredient of Epinefrina Life in the following countries:
International Drug Name Search
In the US, MD-Gastroview is a member of the drug class ionic iodinated contrast media.
Diatrizoic acid calcium, meglumine and sodium salt (a derivative of Diatrizoic acid) is reported as an ingredient of MD-Gastroview in the following countries:
Diatrizoic acid meglumine and sodium salt (a derivative of Diatrizoic acid) is reported as an ingredient of MD-Gastroview in the following countries:
International Drug Name Search
Dipotassium Clorazepate is reported as an ingredient of GenXene in the following countries:
International Drug Name Search
Hydrocodone tartrate (a derivative of Hydrocodone) is reported as an ingredient of Hydrocodone bitartrate and Ibuprofen in the following countries:
Ibuprofen is reported as an ingredient of Hydrocodone bitartrate and Ibuprofen in the following countries:
International Drug Name Search
Iodio Marco Viti may be available in the countries listed below.
Iodine is reported as an ingredient of Iodio Marco Viti in the following countries:
Potassium Iodide is reported as an ingredient of Iodio Marco Viti in the following countries:
International Drug Name Search
Hexopal may be available in the countries listed below.
UK matches:
Inositol Nicotinate is reported as an ingredient of Hexopal in the following countries:
International Drug Name Search
Glossary
SPC | Summary of Product Characteristics (UK) |
Lenicet may be available in the countries listed below.
Aluminium Hydroxide is reported as an ingredient of Lenicet in the following countries:
Aluminium Hydroxide hydrate (Algeldrate) (a derivative of Aluminium Hydroxide) is reported as an ingredient of Lenicet in the following countries:
International Drug Name Search
Histalex may be available in the countries listed below.
Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Histalex in the following countries:
International Drug Name Search
Selenica R may be available in the countries listed below.
Valproic Acid is reported as an ingredient of Selenica R in the following countries:
International Drug Name Search
Salbutamol Pfizer may be available in the countries listed below.
Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Salbutamol Pfizer in the following countries:
International Drug Name Search
Trimedoxine may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Sulfadiazine is reported as an ingredient of Trimedoxine in the following countries:
Trimethoprim is reported as an ingredient of Trimedoxine in the following countries:
International Drug Name Search
Calcitonin-CT may be available in the countries listed below.
Calcitonin is reported as an ingredient of Calcitonin-CT in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Dexamethasone is reported as an ingredient of Dexameth in the following countries:
International Drug Name Search
Hi-Trol may be available in the countries listed below.
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Hi-Trol in the following countries:
International Drug Name Search
Klorhexidin-lidokain SAD may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Klorhexidin-lidokain SAD in the following countries:
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Klorhexidin-lidokain SAD in the following countries:
International Drug Name Search
Ondansetron Copyfarm may be available in the countries listed below.
Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Ondansetron Copyfarm in the following countries:
International Drug Name Search
Marbocyl S may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Marbofloxacin is reported as an ingredient of Marbocyl S in the following countries:
International Drug Name Search
Catapresan may be available in the countries listed below.
Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Catapresan in the following countries:
International Drug Name Search
Modulactone may be available in the countries listed below.
Spironolactone is reported as an ingredient of Modulactone in the following countries:
International Drug Name Search
Cepacaine may be available in the countries listed below.
Benzocaine is reported as an ingredient of Cepacaine in the following countries:
Cetylpyridinium chloride (a derivative of Cetylpyridinium) is reported as an ingredient of Cepacaine in the following countries:
International Drug Name Search
Histazine may be available in the countries listed below.
Cetirizine is reported as an ingredient of Histazine in the following countries:
Cetirizine dihydrochloride (a derivative of Cetirizine) is reported as an ingredient of Histazine in the following countries:
International Drug Name Search
Halonix may be available in the countries listed below.
Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Halonix in the following countries:
International Drug Name Search
Sefro may be available in the countries listed below.
Cefradine is reported as an ingredient of Sefro in the following countries:
International Drug Name Search
Methotrexate Paranova may be available in the countries listed below.
Methotrexate is reported as an ingredient of Methotrexate Paranova in the following countries:
International Drug Name Search
Haldol Decanoato may be available in the countries listed below.
Haloperidol decanoate (a derivative of Haloperidol) is reported as an ingredient of Haldol Decanoato in the following countries:
International Drug Name Search
Petscription Triplegard may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Permethrin is reported as an ingredient of Petscription Triplegard in the following countries:
Piperonyl Butoxide is reported as an ingredient of Petscription Triplegard in the following countries:
Pyrethrin I is reported as an ingredient of Petscription Triplegard in the following countries:
Pyriproxyfen is reported as an ingredient of Petscription Triplegard in the following countries:
International Drug Name Search
Promel may be available in the countries listed below.
Metamizole sodium monohydrate (a derivative of Metamizole) is reported as an ingredient of Promel in the following countries:
International Drug Name Search
Hi-Tac may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Hi-Tac in the following countries:
International Drug Name Search
Sannax may be available in the countries listed below.
Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Sannax in the following countries:
International Drug Name Search
Sedo-Febril Pediatrico may be available in the countries listed below.
Paracetamol is reported as an ingredient of Sedo-Febril Pediatrico in the following countries:
International Drug Name Search
Generic Name: dimethyl sulfoxide (dye METH il sul FOX ide)
Brand Names: Rimso-50
Dimethyl sulfoxide is used to treat pain and swelling associated with bladder or urinary conditions including cystitis (bladder inflammation or irritation).
Dimethyl sulfoxide may also be used for other purposes not listed in this medication guide.
Before you receive dimethyl sulfoxide, tell your doctor if you have cancer of your bladder or kidneys. You may not be able to use this medication, or you may need a dose adjustment or special tests during treatment.
You may notice a garlic- or onion-like taste in your mouth while you are receiving dimethyl sulfoxide. This effect may last for several hours after you receive the medication, and you may also sense these odors on your breath or skin. This is a normal side effect of dimethyl sulfoxide and is not cause for alarm.
Before you receive dimethyl sulfoxide, tell your doctor if you have cancer of your bladder or kidneys. You may not be able to use this medication, or you may need a dose adjustment or special tests during treatment.
Dimethyl sulfoxide is injected directly into the bladder using a catheter or syringe inserted into the urethra (the tube for passing urine out of your bladder). You will receive this medication in a clinic or hospital setting.
After dimethyl sulfoxide is placed into the bladder, you will need to hold the medication in for 15 minutes before emptying your bladder.
Dimethyl sulfate is usually given once every 2 weeks until your symptoms are relieved. Follow your doctor's instructions about your specific dosing schedule.
Your doctor may also recommend other medications to treat pain or bladder spasm. Be sure to read the medication guide or patient instructions provided with each of your medications.
To be sure this medication is helping your condition and not causing harmful effects, your blood will need to be tested on a regular basis. You may also need to have eye exams before and during treatment. Do not miss any scheduled appointments.
Call your doctor for instructions if you miss an appointment for your dimethyl sulfoxide treatment.
An overdose of dimethyl sulfoxide is not expected to produce life-threatening symptoms.
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are being treated with dimethyl sulfoxide.
Tell your caregivers if you feel severe discomfort or irritation when the medication is inserted or while you are holding it in your bladder. This discomfort may become less noticeable over time with repeat treatments.
You may notice a garlic- or onion-like taste in your mouth while you are receiving dimethyl sulfoxide. This effect may last for several hours after you receive the medication, and you may also sense these odors on your breath or skin. This is a normal side effect of dimethyl sulfoxide and is not cause for concern.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
There may be other drugs that can interact with dimethyl sulfoxide. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
See also: Rimso-50 side effects (in more detail)
Isosorbide Mononitrato Dorom may be available in the countries listed below.
Isosorbide Mononitrate is reported as an ingredient of Isosorbide Mononitrato Dorom in the following countries:
International Drug Name Search
bue-PROE-pee-on
Wellbutrin(R) formulations and Forfivo XL: Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies with major depressive disorder (MDD) and other psychiatric disorders. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24, and there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. This risk must be balanced with the clinical need. Monitor patients closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Not approved for use in pediatric patients. Zyban(R): Serious neuropsychiatric events, including depression, suicidal ideation, suicide attempt, and completed suicide, have been reported in patients with and without preexisting psychiatric disease who were taking bupropion for smoking cessation; some experienced worsening of their psychiatric illnesses. All patients should be observed for changes in behavior, hostility, agitation, depressed mood, and suicide-related events, including ideation, behavior, and attempted suicide. The patient should stop taking bupropion and contact a healthcare provider immediately if any neuropsychiatric behavior that is not typical for the patient is observed, or if the patient develops suicidal ideation or suicidal behavior. This risk should be weighed against the benefits of its use .
Antidepressants increased the risk of suicidal thinking and behavior in children, adolescents, and young adults in short-term studies with major depressive disorder (MDD) and other psychiatric disorders. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24, and there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. This risk must be balanced with the clinical need. Monitor patients closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Not approved for use in pediatric patients .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antidepressant
Chemical Class: Aminoketone
Bupropion is used to treat mental depression. It is also used as part of a support program to help people stop smoking. bupropion may also be used to prevent depression in patients with seasonal affective disorder, which is sometimes called winter depression.
Bupropion is sold under different brand names for different uses. If you are already taking medicine for mental depression or to help you stop smoking, discuss this with your doctor before taking bupropion. It is very important that you receive only one prescription for bupropion at a time.
bupropion is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bupropion, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to bupropion or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of bupropion in the pediatric population. Studies with other medicines used for depression have shown that some children, teenagers, and young adults think about suicide or attempt suicide when taking these medicines. Because of this toxicity, use in children is not recommended.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of bupropion in the elderly. However, elderly patients may be more sensitive to the effects of bupropion than younger adults, and are more likely to have age-related kidney or liver problems, which may require caution and an adjustment in the dose for patients receiving bupropion.
Pregnancy Category | Explanation | |
---|---|---|
All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking bupropion, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using bupropion with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using bupropion with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using bupropion with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using bupropion with any of the following is usually not recommended, but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use bupropion, or give you special instructions about the use of food, alcohol, or tobacco.
The presence of other medical problems may affect the use of bupropion. Make sure you tell your doctor if you have any other medical problems, especially:
Use bupropion only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered. To do so, may increase the chance of side effects.
bupropion should come with a Medication Guide. Read and follow these instructions carefully. Ask your doctor if you have any questions.
Use only the brand of bupropion that your doctor prescribed. Different brands may not work the same way.
Swallow the sustained-release tablets whole. Do not break, crush, divide, or chew it.
You may take bupropion with or without food. But, if you have nausea, take bupropion with food.
To lessen stomach upset, bupropion may be taken with food, unless your doctor has told you to take it on an empty stomach.
If you are taking Zyban® tablets to help you stop smoking, you may continue to smoke for about 1 week after you start using bupropion. Then, you should set a target date to quit smoking during your second week of Zyban® treatment. Talk to your doctor if you are having trouble to stop smoking after you have used bupropion for at least 7 weeks.
Do not smoke if you are using a nicotine patch or any other medicine containing nicotine together with Zyban® tablets. To do so, may increase risk for more serious side effects.
bupropion must be taken for several weeks, usually 4 weeks, before you start to feel better. You will probably need to keep taking bupropion for several months to help prevent the return of your depression. Your doctor will check your progress at regular visits, especially during the first few weeks that you take bupropion.
If you have trouble with sleeping (insomnia), do not take bupropion too close to bedtime.
For patients taking the extended-release tablet form of bupropion:
To help you remember to use your medicine, take it at the same time each day.
The dose of bupropion will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of bupropion. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of bupropion, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
If you are taking the extended-release tablets and you miss a dose, skip the missed dose and go back to your regular dosing schedule.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Your doctor will check your progress at regular visits, especially during the first few months that you take bupropion. The amount of bupropion you take may have to be adjusted to meet the needs of your condition and to help avoid unwanted effects.
Do not take bupropion with or within 14 days of taking a drug with monoamine oxidase inhibitor (MAOI) activity (e.g., isocarboxazid [Marplan®], phenelzine [Nardil®], procarbazine [Matulane®], selegiline [Eldepryl®], or tranylcypromine [Parnate®]). Do not take an MAO inhibitor within 14 days of taking bupropion. If you do, you might have convulsions (seizures).
Your blood pressure might get too high while you are using bupropion. This may cause headaches, blurred vision, and other symptoms. You might need to measure your blood pressure at home. If you think your blood pressure is getting too high, call your doctor right away.
Bupropion may cause some people to be agitated, irritable, or display other abnormal behaviors. It may also cause some people to have suicidal thoughts and tendencies or to become more depressed. Make sure the doctor knows if you have trouble sleeping, get upset easily, have a big increase in energy, or start to act reckless. Also tell the doctor if you have sudden or strong feelings, such as feeling nervous, angry, restless, violent, or scared. If you or your caregiver notice any of these side effects, tell your doctor right away.
bupropion may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Stop using bupropion and tell your doctor right away if you have a rash; itching; swelling of the face, tongue, and throat; trouble breathing; or chest pain after you take bupropion.
Serious skin reactions can occur with bupropion. Check with your doctor right away if you have blistering, peeling, or loosening of the skin; red skin lesions; severe acne or skin rash; sores or ulcers on the skin; or fever or chills while you are using bupropion.
Drinking alcoholic beverages should be limited or avoided, if possible, while taking bupropion. This will help prevent seizures.
bupropion may cause some people to have a false sense of well-being, or to become drowsy, dizzy, or less alert than they are normally. Make sure you know how you react to bupropion before you drive, use machines, or do anything else that could be dangerous if you are dizzy or not alert and clearheaded.
Do not stop taking bupropion without checking first with your doctor. Your doctor may want you to gradually reduce the amount you are taking before stopping it completely. This is to decrease the chance of having side effects such as agitation, anxiety, dizziness, a feeling of constant movement of self or surroundings, headache, increased sweating, nausea, trembling or shaking, trouble with sleeping or walking, or unusual tiredness when you stop the medicine.
Check with your doctor right away if you have pain or tenderness in the upper stomach; pale stools; dark urine; loss of appetite; nausea; unusual tiredness or weakness; or yellow eyes or skin. These could be symptoms of a serious liver problem.
bupropion may cause changes in your appetite or weight. Your doctor may need to check your weight regularly during treatment with bupropion.
Before you have any medical tests, tell the medical doctor in charge that you are taking bupropion. The results of some tests may be affected by bupropion.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Get emergency help immediately if any of the following symptoms of overdose occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: bupropion side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Hypoloc may be available in the countries listed below.
Nebivolol hydrochloride (a derivative of Nebivolol) is reported as an ingredient of Hypoloc in the following countries:
International Drug Name Search
Amotein may be available in the countries listed below.
Metronidazole is reported as an ingredient of Amotein in the following countries:
International Drug Name Search
Relieving symptoms of sinus congestion, pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.
Rhinacon A Controlled-Release Tablets are an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, which relieves congestion and pressure.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Rhinacon A Controlled-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Rhinacon A Controlled-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Rhinacon A Controlled-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Rhinacon A Controlled-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Rhinacon A Controlled-Release Tablets.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.
Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; trouble sleeping; vision changes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Rhinacon A side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (http://www.aapcc.org ), or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; vomiting.
Store Rhinacon A Controlled-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rhinacon A Controlled-Release Tablets out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Rhinacon A Controlled-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Azithin may be available in the countries listed below.
Azithromycin is reported as an ingredient of Azithin in the following countries:
International Drug Name Search
Dafalgan Codéine may be available in the countries listed below.
Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Dafalgan Codéine in the following countries:
Paracetamol is reported as an ingredient of Dafalgan Codéine in the following countries:
International Drug Name Search
Helicobacter Test HP-Plus may be available in the countries listed below.
Urea ?1?3C (a derivative of Urea) is reported as an ingredient of Helicobacter Test HP-Plus in the following countries:
International Drug Name Search
Arava is a brand name of leflunomide, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Arava:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Arava. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Arava.
Septocaine is a brand name of articaine/epinephrine, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Septocaine:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Septocaine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Septocaine.
Hidrokortizons may be available in the countries listed below.
Hydrocortisone is reported as an ingredient of Hidrokortizons in the following countries:
International Drug Name Search
Acido cromoglicico may be available in the countries listed below.
Acido cromoglicico (DCIT) is also known as Cromoglicic Acid (Rec.INN)
International Drug Name Search
Glossary
DCIT | Denominazione Comune Italiana |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Amiloretik may be available in the countries listed below.
Amiloride hydrochloride dihydrate (a derivative of Amiloride) is reported as an ingredient of Amiloretik in the following countries:
Hydrochlorothiazide is reported as an ingredient of Amiloretik in the following countries:
International Drug Name Search
Hexomédine may be available in the countries listed below.
Hexamidine diisetionate (a derivative of Hexamidine) is reported as an ingredient of Hexomédine in the following countries:
International Drug Name Search
Heparine Calcique may be available in the countries listed below.
Heparin calcium salt (a derivative of Heparin) is reported as an ingredient of Heparine Calcique in the following countries:
International Drug Name Search
Nitrendipino Ratiopharm may be available in the countries listed below.
Nitrendipine is reported as an ingredient of Nitrendipino Ratiopharm in the following countries:
International Drug Name Search
Némisol may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Levamisole is reported as an ingredient of Némisol in the following countries:
Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Némisol in the following countries:
International Drug Name Search
Nalbuphine Mylan may be available in the countries listed below.
Nalbuphine hydrochloride (a derivative of Nalbuphine) is reported as an ingredient of Nalbuphine Mylan in the following countries:
International Drug Name Search
In the US, Clopine is a member of the drug class atypical antipsychotics and is used to treat Paranoid Disorder and Schizophrenia.
Clozapine is reported as an ingredient of Clopine in the following countries:
International Drug Name Search
Generic Name: duloxetine (du LOX e teen)
Brand Names: Cymbalta
Duloxetine is an antidepressant in a group of drugs called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). Duloxetine affects chemicals in the brain that may become unbalanced and cause depression.
Duloxetine is used to treat major depressive disorder and general anxiety disorder.
Duloxetine is also used to treat fibromyalgia (a chronic pain disorder), or chronic muscle or joint pain (such as low back pain and osteoarthritis pain).
Duloxetine is also used to treat pain caused by nerve damage in people with diabetes (diabetic neuropathy).
Duloxetine may also be used for purposes not listed in this medication guide.
You may have thoughts about suicide when you first start taking an antidepressant, especially if you are younger than 24 years old. Your doctor will need to check you at regular visits for at least the first 12 weeks of treatment.
Treatments for depression are getting better everyday and there are things you can start doing right away.
To make sure you can safely take duloxetine, tell your doctor if you have any of these other conditions:
seizures or epilepsy;
a bleeding or blood clotting disorder;
glaucoma;
bipolar disorder (manic depression); or
a history of drug abuse or suicidal thoughts.
You may have thoughts about suicide while taking an antidepressant, especially if you are younger than 24 years old. Tell your doctor if you have worsening depression or suicidal thoughts during the first several weeks of treatment, or whenever your dose is changed.
Your family or other caregivers should also be alert to changes in your mood or symptoms. Your doctor will need to check you at regular visits for at least the first 12 weeks of treatment.
Older adults may be more sensitive to the side effects of this medication.
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results.
Try to take the medicine at the same time each day. Follow the directions on your prescription label.
See also: Duloxetine dosage (in more detail)
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include agitation, hallucinations, fever, overactive reflexes, loss of coordination, extreme drowsiness, vomiting, diarrhea, seizure (convulsions), fast heart rate, feeling light-headed, or fainting.
Call your doctor at once if you have any of these serious side effects:
nausea, pain in your upper stomach, itching, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
feeling like you might pass out;
agitation, hallucinations, fever, fast heart rate, overactive reflexes;
very stiff (rigid) muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors;
easy bruising, unusual bleeding;
painful or difficult urination;
headache, trouble concentrating, memory problems, weakness, feeling unsteady, loss of coordination, fainting, seizure, shallow breathing or breathing that stops; or
severe skin reaction -- fever, sore throat, swelling in your face or tongue, burning in your eyes, skin pain, followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.
Less serious side effects may include:
dry mouth;
drowsiness;
tired feeling;
mild nausea or loss of appetite; or
constipation.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Pain:
For use in the management of neuropathic pain associated with diabetic peripheral neuropathy and for the management of chronic musculoskeletal pain in patients with chronic low back pain and chronic pain due to osteoarthritis:
Usual Dose: 60 mg once a day without regard to meals.
For patients in whom tolerability is a concern, a lower starting dose may be considered.
Although a 120 mg per day dose was shown to be safe and effective, there is no evidence that doses higher than 60 mg have any additional benefit. Furthermore, the higher dose has been clearly less well tolerated.
Efficacy beyond 12 weeks has not been systematically studied in placebo-controlled studies, but a one year open label safety study has been conducted.
Usual Adult Dose for Depression:
Initial Dose: 40 mg per day (administered as 20 mg twice daily) to 60 mg per day (given either once a day or as 30 mg twice daily) without regard to meals.
Usual Adult Dose for Anxiety:
Initial dose: 60 mg orally once a day If necessary, dosage may be increased in increments of no more than 30 mg per day Maximum dose: 120 mg per day For patients in whom tolerability is a concern, a lower an initial dose of 30 mg orally once a day may be considered. Following one week of therapy, the dose may be increased to 60 mg orally once a day in this patient population. Although a 120 mg per day dose was shown to be safe and effective, there is no evidence that doses higher than 60 mg have any additional benefit.
It is generally agreed that episodes of generalized anxiety disorder require several months or longer of sustained pharmacological therapy. Maintenance of efficacy in generalized anxiety disorder has been demonstrated with duloxetine as monotherapy. Duloxetine should be administered in a dose range of 60 to 120 mg once daily. Patients should be periodically reassessed to determine the continued need for maintenance treatment and the appropriate dose for such treatment.
Usual Adult Dose for Fibromyalgia:
Initial Dose: 30 mg once a day without regard to meals for one week.
Usual Dose: 60 mg once a day without regard to meals.
Treatment should begin at 30 mg once daily for 1 week, to allow patients to adjust to the medication before increasing to 60 mg once daily. Some patients may respond to the starting dose. There is no evidence that doses greater than 60 mg/day confer additional benefit, even in patients who do not respond to a 60 mg dose, and higher doses are associated with a higher rate of adverse reactions.
Fibromyalgia is recognized as a chronic condition. The efficacy of duloxetine in the management of fibromyalgia has been demonstrated in placebo-controlled studies up to three months. The efficacy of duloxetine was not demonstrated in longer studies; however, continued treatment should be based on individual patient response.
Talk to your doctor before taking any medicine for pain, arthritis, fever, or swelling. This includes aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve, Naprosyn), diclofenac (Voltaren), indomethacin, piroxicam (Feldene), nabumetone (Relafen), etodolac (Lodine), and others. Taking any of these drugs with duloxetine may cause you to bruise or bleed easily.
Tell your doctor about all other medicines you use, especially:
a blood thinner such as warfarin (Coumadin);
cimetidine (Tagamet);
a diuretic (water pill);
fluvoxamine (Luvox);
linezolid (Zyvox);
lithium (Lithobid, Eskalith);
St. John's wort;
tramadol (Ultram);
tryptophan (sometimes called L-tryptophan);
an antibiotic such as ciprofloxacin (Cipro);
almotriptan (Axert), frovatriptan (Frova), sumatriptan (Imitrex), naratriptan (Amerge), rizatriptan (Maxalt), or zolmitriptan (Zomig); or
any other antidepressant such as desipramine (Norpramin), fluoxetine (Prozac, Sarafem), paroxetine (Paxil), and others.
This list is not complete and other drugs may interact with duloxetine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: duloxetine side effects (in more detail)